Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action

References

• SacksJJLuoYHHelmickCGPrevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001–2005Arthritis Care Res (Hoboken)201062446046420391499
   PubMed Web of Science ®Google Scholar
• DavisJM3rdMattesonELAmerican College of Rheumatology, European League Against RheumatismMy treatment approach to rheumatoid arthritisMayo Clin Proc201287765967322766086
   PubMed Web of Science ®Google Scholar
• SinghJACameronDRSummary of AHRQ’s comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an updateJ Manag Care Pharm2012184 Supp CS118
   Google Scholar
• ShoenfeldYGerliRDoriaAAccelerated atherosclerosis in autoimmune rheumatic diseasesCirculation2005112213337334716301360
   PubMed Web of Science ®Google Scholar
• BlumlSRedlichKSmolenJSMechanisms of tissue damage in arthritisSemin Immunopathol201436553154025212687
   PubMed Web of Science ®Google Scholar
• GuidelliGMBarskovaTBriziMGOne year in review: novelties in the treatment of rheumatoid arthritisClin Exp Rheumatol201533110210825719499
   PubMed Web of Science ®Google Scholar
• CurtisJRSinghJAUse of biologics in rheumatoid arthritis: current and emerging paradigms of careClin Ther201133667970721704234
   PubMed Web of Science ®Google Scholar
• EmeryPSebbaAHuizingaTWBiologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritisAnn Rheum Dis201372121897190423918035
   PubMed Web of Science ®Google Scholar
• FelsonDTSmolenJSWellsGAmerican College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trialsArthritis Rheum201163357358621294106
   PubMed Web of Science ®Google Scholar
• ChikanzaICKozaciDLCorticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectivesRheumatology (Oxford)200443111337134515304669
   PubMed Web of Science ®Google Scholar
• GhalyNRKotbNANagyHMRageh elSMToll-like receptor 9 in systemic lupus erythematosus, impact on glucocorticoid treatmentJ Dermatolog Treat201324641141722620859
   PubMed Web of Science ®Google Scholar
• SekiMUshiyamaCSetaNApoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosusArthritis Rheum19984158238309588733
   PubMed Web of Science ®Google Scholar
• WallaceDJGoldfingerDSavageGPredictive value of clinical, laboratory, pathologic, and treatment variables in steroid/immunosup-pressive resistant lupus nephritisJ Clin Apher19884130343391988
   PubMedGoogle Scholar
• FiehnCKesslerSMullerKMorning stiffness of the joints is the sole predictor of short-term response to glucocorticoid treatment in active rheumatoid arthritis (RA)Rheumatol Int201232124069407021935726
   PubMed Web of Science ®Google Scholar
• QuaxRAManenschijnLKoperJWGlucocorticoid sensitivity in health and diseaseNat Rev Endocrinol201391167068624080732
   PubMed Web of Science ®Google Scholar
• Sliwinska-StanczykPPazdurJZiolkowskaMJaworskiJKaminska-TchorzewskaELackiJKThe effect of methylprednisolone on proliferation of PBMCs obtained from steroid-sensitive and steroid-resistant rheumatoid arthritis patientsScand J Rheumatol200736316717117657668
   PubMed Web of Science ®Google Scholar
• van SchaardenburgDValkemaRDijkmansBAPrednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatmentArthritis Rheum19953833343427880187
   PubMed Web of Science ®Google Scholar
• PapagorasCVoulgariPVDrososAAStrategies after the failure of the first anti-tumor necrosis factor alpha agent in rheumatoid arthritisAutoimmun Rev20109857458220433955
   PubMed Web of Science ®Google Scholar
• Rendas-BaumRWallensteinGVKonczTEvaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-alpha inhibitorsArthritis Res Ther2011131R2521324169
   PubMed Web of Science ®Google Scholar
• ActharHP(R) Gel (repository corticotropin injection) [package insert]Hazelwood, MOMallinckrodt ARD Inc.2015 Available from: http://www.acthar.com/pdf/Acthar-PI.pdfAccessed November 19, 2015
   Google Scholar
• HenchPSKendallECSlocumbCHPolleyHFThe effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritisProc Staff Meet Mayo Clin194924818119718118071
   PubMed Web of Science ®Google Scholar
• Montero-MelendezTACTH: the forgotten therapySemin Immunol201527321622625726511
   PubMed Web of Science ®Google Scholar
• AletahaDNeogiTSilmanAJ2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeArthritis Rheum20106292569258120872595
   PubMed Web of Science ®Google Scholar
• SmolenJSAletahaDBijlsmaJWTreating rheumatoid arthritis to target: recommendations of an international task forceAnn Rheum Dis201069463163720215140
   PubMed Web of Science ®Google Scholar
• AilingerRLDearMRSelf-care agency in persons with rheumatoid arthritisArthritis Care Res1993631341408130289
   PubMedGoogle Scholar
• HawkerGAMianSKendzerskaTFrenchMMeasures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)Arthritis Care Res (Hoboken)201163S11S240S25222588748
   PubMed Web of Science ®Google Scholar
• BartonJLImbodenJGrafJGliddenDYelinEHSchillingerDPatient-physician discordance in assessments of global disease severity in rheumatoid arthritisArthritis Care Res (Hoboken)201062685786420535797
   PubMed Web of Science ®Google Scholar
• KeenanRTSwearingenCJYaziciYErythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patientsClin Exp Rheumatol200826581481919032813
   PubMed Web of Science ®Google Scholar
• CataniaAGattiSColomboGLiptonJMTargeting melanocortin receptors as a novel strategy to control inflammationPharmacol Rev200456112915001661
   PubMed Web of Science ®Google Scholar
• GettingSJTargeting melanocortin receptors as potential novel therapeuticsPharmacol Ther2006111111516488018
   PubMed Web of Science ®Google Scholar
• CataniaAThe melanocortin system in leukocyte biologyJ Leukoc Biol200781238339217041004
   PubMed Web of Science ®Google Scholar
• BohmMGrasselSRole of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational researchEndocr Rev201233462365122736674
   PubMed Web of Science ®Google Scholar
• PatelHBBombardieriMSampaioALAnti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritisFASEB J201024124835484320702773
   PubMed Web of Science ®Google Scholar
• ZhongQSridharSRuanLMultiple melanocortin receptors are expressed in bone cellsBone200536582083115804492
   PubMed Web of Science ®Google Scholar
• EricsonMDLensingCJFlemingKASchlasnerKNDoeringSRHaskell-LuevanoCBench-top to clinical therapies: a review of melanocortin ligands from 1954 to 2016Biochim Biophys Acta Epub2017329
   Web of Science ®Google Scholar